Panbela Therapeutics Overview

Panbela Therapeutics Selling, General & Admin

Selling, General & Admin expenses for PBLA.

Quarterly SG&A Expenses

$1.11M

↑ 0.54% YoY

As of Sep 30, 2024

Annual SG&A Expenses (TTM)

$4.35M

↓ 24.45% YoY

Trailing 12 months ending Sep 30, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin